Fourteen years clinical trial experience with the ChlVPP/EVA hybrid regimen as first line treatment for advanced Hodgkin's disease (HD)
Autor: | John Radford, Azs, Rohatiner, Wdj, Ryder, Dp, Deakin, Barbui, T., Lucie, N., Rossi, A., Dj, Dunlop, Rd, James, Rk, Gupta, Ra, Cowan, Shamash, J., Joan Chang, Ta, Lister |
---|---|
Zdroj: | University of Manchester-PURE |
Databáze: | OpenAIRE |
Externí odkaz: |